Matrix metalloproteinase inhibition. From the Jurassic to the third millennium

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 388-403

  Woessner Jr , J Frederick ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; CARBONYL DERIVATIVE; CHELATING AGENT; HYDROXAMIC ACID; MATRIX METALLOPROTEINASE; TETRACYCLINE DERIVATIVE; THIOL; TISSUE INHIBITOR OF METALLOPROTEINASE;

CONFERENCE PAPER; DRUG DESIGN; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; NONHUMAN;

EID: 0032864538     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07697.x     Document Type: Conference Paper

References (111)

1. 1. Gross, J. & C.M. Lapière. 1962. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl. Acad. Sci. USA 48: 1014-1022.
2. 2. Gross, J. & Y. Nagai. 1965. Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc. Natl. Acad. Sci. USA 54: 1197-1204.
3. 3. Bauer, E.A., A.Z. Eisin & J.J. Jeffrey. 1970. Immunologic relationship of a purified human skin collagenase to other human and animal collagenases. Biochim. Biophys. Acta 206: 152-160.
4. 4. Harper, E., K.J. Bloch & J. Gross. 1971. The zymogen of tadpole collagenase. Biochemistry 10: 3035-3041.
5. 5. Lazarus, G.S., R.S. Brown, J.R. Daniels & H.M. Fullmer. 1968. Human granulocyte collagenase. Science 159: 1483-1485.
6. 6. Werb, Z. & J.J. Reynolds. 1974. Stimulation by endocytosis of the secretion of collagenase and neutral proteinase from rabbit synovial fibroblasts. J. Exp. Med. 140: 1482-1497.
7. 7. Sopata, I. & A.M. Dancewicz. 1974. Presence of a gelatin-specific proteinase and its latent form in human leucocytes. Biochim. Biophys. Acta 370: 510-523.
8. 8. Sellers, A., J.J. Reynolds & M.C. Meikle. 1978. Neutral metallo-proteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans. Biochem. J. 171: 493-496.
9. 9. Sellers, A. & J.F. Woessner, Jr. 1980. The extraction of a neutral metalloproteinase from the involuting rat uterus, and its action on cartilage proteoglycan. Biochem. J. 189: 521-531.
10. 10. Banda, M.J., E.J. Clark & Z. Werb. 1980. Limited proteolysis by macrophage clastase inactivates human alpha 1-proteinase inhibitor. J. Exp. Med. 152: 1563-1570.
11. 11. Breathnach, R., L.M. Matrisian, M.-C. Gesnel, A. Staub & P. Leroy. 1987. Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acids Res. 15: 1139-1151.
12. 12. Basset, P., J.P. Bellocq, C. Wolf, I. Stoll, P. Hutin et al. 1990. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704.
13. 13. Freije, J.M., I. Díez-Itza, M. Balbin, L.M. Sánchez, R. Blasco et al. 1994. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269: 16766-16773.
14. 14. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa et al. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
15. 15. Will, H. & B. Hinzmann. 1995. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231: 602-608.
16. 16. Takino, T., H. Sato, A. Shinagawa & M. Seiki. 1995. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270: 23013-23020.
17. 17. Puente, X.S., A.M. Pendás, E. Llano, G. Velasco & C. López-Otín. 1996. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56: 944-949.
18. 18. Stolow, M.A., D.D. Bauzon, J. Li, T. Sedgwick, V.C. Liang et al. 1996. Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol. Biol. Cell 7: 1471-1483.
19. 19. Karlson, J., A.K. Borg-Karlson, R. Unelius, M.C. Shoshan, N. Wilking et al. 1996. Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action. Anticancer Drugs 7: 422-429.
20. 20. Bartlett, J.D., J.P. Simmer, J. Xue, H.C. Margolis & E.C. Moreno. 1996. Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene 183: 123-128.
21. 21. Yang, M.Z., M.T. Murray & M. Kurkinen. 1997. A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development. J Biol. Chem. 272: 13527-13533.
22. 22. Nagai, Y., C.M. Lapière & J. Gross. 1966. Tadpole collagenase. Preparation and purification. Biochemistry 5: 3123-3130.
23. 23. Berman, M.B. & R. Manabe. 1973. Corneal collagenases: evidence for zinc metalloenzymes. Ann. Ophthalmol. 5: 1193-1209.
24. 24. Brown, S.I., S. Akiya & C.A. Weller. 1969. Prevention of the ulcers of the alkali-burned cornea. Preliminary studies with collagenase inhibitors. Arch. Ophthalmol. 82: 95-97.
25. 25. Parks, W.C. & R.P. Mecham. 1998. Matrix Metalloproteinases. Academic Press. San Diego, CA.
26. 26. Woessner, J.F., Jr. 1998. The matrix metalloproteinase family. In Matrix Metalloproteinases. W.C. Parks & R.P. Mecham, Eds. :1-14. Academic Press. San Diego, CA.
27. 27. Mecham, R.P., T.J. Broekelmann, C.J. Fliszar, S.D. Shapiro, H.G. Welgus et al. 1997. Elastin degradation by matrix metalloproteinases - cleavage site specificity and mechanisms of clastolysis. J. Biol. Chem. 272: 18071-18076.
28. 28. D'Armiento, J., S.S. Dalal, Y. Okada, R.A. Berg & K. Chada. 1992. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71: 955-961.
29. 29. D'Armiento, J., T. Dicolandrea, S.S. Dalal, Y. Okada, M.T. Huang et al. 1995. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell. Biol. 15: 5732-5739.
30. 30. Sympson, C.J., R.S. Talhouk, C.M. Alexander, J.R. Chin, S.M. Clift et al. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue- specific gene expression. J. Cell Biol. 125: 681-693.
31. 31. Rudolph-Owen, L.A., P. Cannon & L.M. Matrisian. 1998. Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility. Mol. Biol.Cell 9: 421-435.
32. 32. Liu, X., H. Wu, M. Byrne, J. Jeffrey, S. Krane et al. 1995. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell Biol. 130: 227-237.
33. 33. Itoh, T., M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto et al. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58: 1048-1051.
34. 34. Rudolph-Owen, L.A., D.L. Hulboy, C.L. Wilson, J. Mudgett & L.M. Matrisian. 1997. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology 138: 4902-4911.
35. 35. Masson, R., O. Lefebvre, A. Noel, M. El Fahime, M.P. Chenard et al. 1998. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol. 140: 1535-1541.
36. 36. Wilson, C.L., K.J. Heppner, P.A. Labosky, B.L. Hogan & L.M. Matrisian. 1997. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA 94: 1402-1407.
37. 37. Vu, T.H., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms et al. 1998. MMP-9/ gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422.
38. 38. Hautamaki, R.D., D.K. Kobayashi, R.M. Senior & S.D. Shapiro. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004.
39. 39. Witty, J.P., S. McDonnell, K.J. Newell, P. Cannon, M. Navre et al. 1994. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res. 54: 4805-4812.
40. 40. Yamamoto, H., F. Itoh, Y. Hinoda & K. Imai. 1995. Suppression of matrilysin inhibits colon cancer cell invasion in vitro. Int. J. Cancer 61: 218-222.
41. 41. Deryugina, E.I., G.X. Luo, R.A. Reisfeld, M.A. Bourdon & A. Strongin. 1997. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res. 17: 3201-3210.
42. 42. Turck, J., A.S. Pollock, L.K. Lee, H.P. Marti & D.H. Lovett. 1996. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J. Biol. Chem. 271: 15074-15083.
43. 43. Lochter, A., A. Srebrow, C.J. Sympson, N. Terracio, Z. Werb et al. 1997. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J. Biol. Chem. 272: 5007-5015.
44. 44. Draper, K.G., P. Pavco, J. McSwiggen, J. Gustofson, & D.T. Stinchcomb, invetors; Ribozyme Pharmaceuticals, assignee. 1997. Ribozymes that cleave human stromelysin mRNA and can be used as inflammation inhibitors or for arthritis treatment. US Patent 5,612,215, pp.1-241. Application date: February 17, 1995.
45. 45. Hayakawa, T., N. Fujimoto, R.V. Ward & K. Iwata. 1994. Interaction between progelatinase A and TIMP-2. Ann. N. Y. Acad. Sci. 732: 389-391.
46. 46. Hua, J. & R.J. Muschel. 1996. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res. 56: 5279-5284.
47. 47. Melong, R.K. & P.S. Miller. 1996. Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonates. Antisense Nucleic Acid Drug Dev. 6: 273-280.
48. 48. Nagase, H., Y. Itoh & S. Binner. 1994. Interaction of alpha 2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms. Ann. N. Y. Acad. Sci. 732: 294-302.
49. 49. Yu, W.-H. & J.F. Woessner, Jr. 1997. Binding of matrilysin to glycosaminoglycan [abstract]. FASEB J. 9: A1227.
50. 50. Mallya, S.K. & H.E. Van Wart. 1989. Mechanism of inhibition of human neutrophil collagenase by gold(I) chrysotherapeutic compounds. Interaction at a heavy metal binding site. J. Biol. Chem. 264: 1594-1601.
51. 51. Wauters, P., Y. Eeckhout & G. Vaes. 1986. Oxidation products are responsible for the resistance to the action of collagenase conferred on collagen by (+)-catechin. Biochem. Pharmacol. 35: 2971-2973.
52. 52. Masui, Y., T. Takemoto, S. Sakakibara, H. Hori & Y. Nagai. 1977. Synthetic substrates for vertebrate collagenase. Biochem. Med. 17: 215-221.
53. 53. Gray, R.D., H.H. Saneii & A.F. Spatola. 1981. Metal binding peptide inhibitors of vertebrate collagenase. Biochem. Biophys. Res. Commun. 101: 1251-1258.
54. 54. McCullagh, K., H. Wadsworth, & M. Hann, inventors; G.D. Searle & Co., assignee. 1984. Carboxyalkyl peptide derivatives. Eur. Patent No. 126,974, pp. 1-111. Date of application: April 26, 1983.
55. 55. Delaissé J.M., Y. Eeckhout, C. Sear, A. Galloway, K. McCullagh et al. 1985. A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. Biochem. Biophys. Res. Commun. 133: 483-490.
56. 56. Brännström, M., J.F. Woessner, Jr., R.D. Koos, C.H. Sear & W.J. Lemaire. 1988. Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovulation in the perfused rat ovary. Endocrinology 122: 1715-1721.
57. 57. Butler, T.A., C. Zhu, R.A. Mueller, G.C. Fuller, W.J. Lemaire & J.F. Woessner, Jr. 1991. Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463. Biol. Reprod. 44: 1183-1188.
58. 58. Galardy, R.E., D. Grobelny, Z.P. Korylewicz & L. Poncz. 1992. Inhibition of human skin collagenase by phosphorus-containing peptides. Matrix Suppl. 1: 259-262.
59. 59. Lovejoy, B., A. Cleasby, A.M. Hassell, K. Longley, M.A. Luther et al. 1994. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 263: 375-377.
60. 60. Morphy, J.R., N.R.A. Beeley, B.A. Boyce, J. Leonard, B. Mason et al. 1994. Potent and selective inhibitors of gelatinase A. 2. Carboxylic and phosphonic acid derivatives. Bioorg. Med. Chem. Lett. 4: 2747-2752.
61. 61. Esser, C.K., N.J. Kevin, N.A. Yates & K.T. Chapman. 1997. Solid-phase synthesis of a N-carboxyalkyl tripeptide combinatorial library. Bioorg. Med. Chem. Lett. 7: 2639-2644.
62. 62. Levin, J.I., J.F. DiJoseph, L.M. Killar, M.A. Sharr, J.S. Skotnicki et al 1998. The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases. Bioorg. Med. Chem. Lett. 8: 1163-1168.
63. 63. Chen, J.J., Y.P. Zhang, S. Hammond, N. Dewdney, T. Ho et al. 1996. Design, synthesis, activity & structure of a novel class of matrix metalloproteinase inhibitors containing a heterocyclic P-2′-P-3′ amide bond isostere. Bioorg. Med. Chem. Lett. 6: 1601-1606.
64. 64. Levy, D.E., F. Lapierre, W.S. Liang, W.Q. Ye, C.W. Lange et al. 1998. Matrix metalloproteinase inhibitors - a structure-activity study. J. Med. Chem. 41: 199-223.
65. 65. MacPherson, L.J., E.K. Bayburt, M.P. Capparelli, B.J. Carroll, R. Goldstein et al. 1997. Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J. Med. Chem. 40: 2525-2532.
66. 66. Wojtowicz-Praga, S., J. Low, J. Marshall, E. Ness, R. Dickson et al. 1996. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer. Invest. New Drugs 14: 193-202.
67. 67. Lewis, E.J., J. Bishop, K.M.K. Bottomley, D. Bradshaw, M. Brewster et al. 1997. Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo. Br. J. Pharmacol. 121: 540-546.
68. 68. Brown, P.D. 1998. Synthetic inhibitors of matrix metalloproteinases. In Matrix Metalloproteinases. W.C. Parks and R.P. Mecham, Eds. :243-261. Academic Press. San Diego, CA.
69. 69. Faucher, D.C., Y. Lelièvre & T. Cartwright. 1987. An inhibitor of mammalian collagenase active at micromolar concentrations from an actinomycete culture broth. J. Antibiot. (Tokyo) 40: 1757-1761.
70. 70. Ogita, T., A. Sato, R. Enokita, K. Suzuki, M. Ishii et al. 1992. Matlystatins, new inhibitors of typeIV collagenases from Actinomadura atramentaria. I. Taxonomy, fermentation, isolation, and physico-chemical properties of matlystatin-group compounds. J. Antibiot. (Tokyo) 45: 1723-1732.
71. 71. Tamaki, K., K. Tanzawa, S. Kurihara, T. Oikawa, S. Monma et al. 1995. Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins. Chem. Pharm. Bull. (Tokyo) 43: 1883-1893.
72. 72. Suzuki, K., K. Shimada, S. Nozoe, K. Tanzawa & T. Ogita. 1996. Isolation of nicotianamine as a gelatinase inhibitor. J. Antibiot. (Tokyo) 49: 1284-1285.
73. 73. Golub, L.M., H.M. Lee, G. Lehrer, A. Nemiroff, T.F. McNamara et al. 1983. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J. Periodont. Res. 18: 516-526.
74. 74. Golub, L.M., T.F. McNamara, G. D'Angelo, R.A. Greenwald & N.S. Ramamurthy. 1987. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J. Dent. Res. 66: 1310-1314.
75. 75. Sorsa, T., N.S. Ramamurthy, A.T. Vernillo, X. Zhang, Y.T. Konttinen et al. 1998. Functional sites of chemically modified tetracyclines - inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases. J. Rheumatol. 25: 975-982.
76. 76. Uitto, V.-J., J.D. Firth, L. Nip & L.M. Golub. 1994. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann. N. Y. Acad. Sci. 732: 140-151.
77. 77. Jonat, C., F.Z. Chung & V.M. Baragi. 1996. Transcriptional downregulation of stromelysin by tetracycline. J. Cell. Biochem. 60: 341-347.
78. 78. Stetler-Stevenson, W.G., J.A. Talano, M.E. Gallagher, H.C. Krutzsch & L.A. Liotta. 1991. Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. Am. J. Med. Sci. 302: 163-170.
79. 79. Fotouhi, N., A. Lugo, M. Visnick, L. Lusch, R. Walsky et al. 1994. Potent peptide inhibitors of stromelysin based on the prodomain region of matrix metalloproteinases. J. Biol. Chem. 269: 30227-30231.
80. 80. Bauer, E.A., G.P. Stricklin, J.J. Jeffrey & A.Z. Eisen. 1975. Collagenase production by human skin fibroblasts. Biochem. Biophys. Res. Commun. 64: 232-240.
81. 81. Woolley, D.E., D.R. Roberts & J.M. Evanson. 1975. Inhibition of human collagenase activity by a small molecular weight serum protein. Biochem. Biophys. Res. Commun. 66: 747-754.
82. 82. Welgus, H.G., G.P. Stricklin, A.Z. Eisen, E.A. Bauer, R.V. Cooney et al. 1979. A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J. Biol. Chem. 254: 1938-1943.
83. 83. Cawston, T.E., W.A. Galloway, E. Mercer, G. Murphy & J.J. Reynolds. 1981. Purification of rabbit bone inhibitor of collagenase. Biochem. J. 195: 159-165.
84. 84. Docherty, A.J.P., A. Lyons, B.J. Smith, E.M. Wright, P.E. Stephens et al. 1985. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318: 66-69.
85. 85. Herron, G.S., M.J. Banda, E.J. Clark, J. Gavrilovic & Z. Werb. 1986. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem. 261: 2814-2818.
86. 86. DeClerck, Y.A. 1988. Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells. Arch. Biochem. Biophys. 265: 28-37.
87. 87. Stetler-Stevenson, W.G., H.C. Krutzsch & L.A. Liotta. 1989. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the rnetalloproteinase inhibitor family. J. Biol. Chem. 264: 17374-17378.
88. 88. Blenis, J. & S.P. Hawkes. 1983. Transformation-sensitive protein associated with the cell substratum of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 80: 770-774.
89. 89. Staskus, P.W., F.R. Masiarz, L.J. Pallanck & S.P. Hawkes. 1991. The 21-kDa protein is a transformation-sensitive metalloproteinase inhibitor of chicken fibroblasts. J. Biol. Chem. 266: 449-454.
90. 90. Pavloff, N., P.W. Staskus, N.S. Kishnani & S.P. Hawkes. 1992. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J. Biol. Chem. 267: 17321-17326.
91. 91. Greene, J., M. Wang, Y.E. Liu, L.A. Raymond, C. Rosen et al. 1996. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271: 30375-30380.
92. 92. Gomez, D.E., D.F. Alonso, H. Yoshui & U.P. Thorgeirsson. 1997. Tissue inhibitors of metalloproteinases - structure, regulation and biological functions. Eur. J. Cell. Biol. 74: 111-122.
93. 93. Windsor, L.J., D.L. Steele, S.B. LeBlanc & K.B. Taylor. 1997. Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysin. Biochim. Biophys. Acta 1334: 261-272.
94. 94. Murphy, G., A. Houbrechts, M.I. Cockett, R.A. Williamson, M. O'Shea et al. 1991. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30: 8097-8102.
95. 95. Crabbe, T., S.M. Kelly & N.C. Price. 1996. An analysis of the conformational changes that accompany the activation and inhibition of gelatinase A. FEBS Lett. 380: 53-57.
96. 96. D'Ortho, M.P., H. Stanton, M. Butler, S.J. Atkinson, G. Murphy et al. 1998. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett. 421: 159-164.
97. 97. Gomis-Rüth, F.X., K. Maskos, M. Betz, A. Bergner, R. Huber et al. 1997. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77-81.
98. 98. Hayakawa, T., K. Yamashita, E. Ohuchi & A. Shinagawa. 1994. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell Sci. 107: 2373-2379.
99. 99. Chesler, L., D.W. Golde, N. Bersch & M.D. Johnson. 1995. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood 86: 4506-4515.
100. 100. Nagase, H., K. Suzuki, Y. Itoh, C.C. Kan, M.R. Gehring et al. 1996. Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation. Adv. Exp. Med. Biol. 389: 23-31.
101. 101. Flory, C.M., P.A. Pavco, T.C. Jarvis, M.E. Lesch, F.E. Wincott et al. 1996. Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint. Proc. Natl. Acad. Sci. USA 93: 754-758.
102. 102. Pei, D. & S.J. Weiss. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244-247.
103. 103. Maquoi, E., A. Noel, F. Frankenne, H. Angliker, G. Murphy et al. 1998. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett. 424: 262-266.
104. 104. Nagase, H. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378: 151-160.
105. 105. Lijnen, H.R., B. Vanhoef, F. Lupu, L. Moons, P. Carmeliet et al. 1998. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arteriosel. Thromb. Vasc. Biol. 18: 1035-1045.
106. 106. Smith, G.N., L.P. Yu, K.D. Brandt & W.N. Capello. 1998. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage. J. Rheumatol. 25: 532-535.
107. 107. Seftor, R.E.B., E.A. Seftor, J.E. De Larco, D.E. Kleiner, J. Leferson et al. 1998. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin. Exp. Metast. 16: 217-225.
108. 108. Fife, R.S., G.W. Sledge, B.J. Roth & C. Proctor. 1998. Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett. 127: 37-41.
109. 109. Black, R.A., C.T. Rauch, C.J. Kozlosky, J.J. Peschon, J.L. Slack et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733.
110. 110. Black, R.A., F.H. Durie, C. Otten-Evans, R. Miller, J.L. Slack et al. 1996. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP. Biochem. Biophys. Res. Commun. 225: 400-405.
111. 111. Dimartino, M., C. Wolff, W. High, G. Stroup, S. Hoffman et al. 1997. Antiarthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNF-alpha processing. Inflamm. Res. 46: 211-215.